Skip to content

Gamma‐hydroxybutyrate increases brain resting‐state functional connectivity of the salience network and dorsal nexus in humans

Oliver G. Bosch, F. Esposito, Dario Dornbierer, Michael M. Havranek, Robin von Rotz, M. Kometer, Philipp Staempfli, Boris B. Quednow, Erich Seifritz

Neuroimage June 1, 2018 DOI: 10.1016/j.neuroimage.2018.03.011 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 19
Population Healthy male subjects
Dose 35 mg/kg p. o.
Measures functional magnet resonance imaging, independent component analysis, seed-based analyses, visual analog scales (VAS)
Key findings GHB produced a mixed stimulant/sedative subjective state alongside a complex pattern of increased resting-state functional connectivity involving all three core neurocognitive networks. Intrinsic DMN and CEN connectivity remained largely unchanged, but salience network connectivity increased to the DMN and dorsal nexus, and dorsal nexus connectivity increased to the right anterior insula (SN) and right middle frontal gyrus (CEN). Increased sedation predicted the SN-dorsal nexus connectivity, which the authors propose as a potential signature of the drug's sedative component.

Abstract

&NA; According to the triple network hypothesis the brain is equipped with three core neurocognitive networks: the default mode (DMN), the salience (SN), and the central executive (CEN) network. Moreover, the so called dorsal nexus, has met growing interest as it is a hub region connecting these three networks. Assessment of resting‐state functional connectivity (rsFC) of these networks enables the elucidation of drug‐induced brain alterations. Gamma‐hydroxybutyrate (GHB) is a GHB/GABA‐B receptor agonist that induces a paradoxical state of mixed stimulation and sedation at moderate doses, which makes it a valuable tool to investigate neural signatures of subjective drug effects. Employing a placebo‐controlled, double‐blind, randomized, cross‐over design, we assessed the effects of GHB (35 mg/kg p. o.) in 19 healthy male subjects on DMN‐, SN‐, CEN‐, and dorsal nexus‐rsFC measured by functional magnet resonance imaging and applying independent component as well as seed‐based analyses, while subjective drug effects were investigated using visual analog scales (VAS). Subjectively, GHB increased VAS ratings of a general drug effect, stimulation, and sedation. Intrinsic DMN‐, and CEN‐rsFC remained largely unchanged under GHB, but the drug increased SN‐DMN‐rsFC and SN‐dorsal nexus‐rsFC, while dorsal nexus‐rsFC was reciprocally increased to both the SN (right anterior insula) and to the CEN (right middle frontal gyrus). Increased sedation significantly predicted the observed SN‐dorsal nexus‐rsFC. In conclusion, GHB generates a unique stimulant/sedative subjective state that is paralleled by a complex pattern of increased functional connectivity encompassing all three core neurocognitive networks of the brain, while increased SN‐dorsal nexus‐rsFC was demonstrated to be a potential signature of the sedative component of the drug effect. HighlightsGHB increases salience network functional connectivity to the default mode network in humans.GHB increases salience network functional connectivity to the dorsal nexus in humans.GHB increases dorsal nexus functional connectivity to the right salience and the right executive control network in humans.Sedation is mediated by increased salience network functional connectivity to the dorsal nexus.

Citations in the library

Explore topics